(Q51768835)
Statements
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. (English)
1 reference
1 reference
Susan M Blaney
1 reference
Mason Bond
1 reference
Mark L Bernstein
1 reference
Alberto Pappo
1 reference
Mark Krailo
1 reference
Peter C Adamson
1 reference
1 February 2008
1 reference
50
1 reference
2
1 reference
254-258
1 reference